AYK Hospital
Lahore, Pakistan
NCT Number: NCT07048652
This will be a cross-sectional descriptive study aimed at evaluating the role of high-resolution computed tomography (HRCT) in diagnosing Idiopathic Pulmonary Fibrosis (IPF).
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Lahore, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High-resolution computed tomography (HRCT) plays a crucial role in diagnosing and managing Idiopathic Pulmonary Fibrosis (IPF). It helps identify the characteristic pattern of IPF, known as Usual Interstitial Pneumonia (UIP), and can sometimes obviate the need for lung biopsy.
Time frame: 12 Months
Idiopathic Pulmonary Fibrosis (IPF) high-resolution computed tomography (HRCT) scans are crucial for diagnosis and assessment of disease severity. HRCT findings typically show a reticular pattern with traction bronchiectasis and honeycombing, predominantly in the subpleural and basal regions of the lungs
Superior University
Other
Evaluating the Diagnostic Performance of High-Resolution Computed Tomography (HRCT) in Detecting Idiopathic Pulmonary Fibrosis (IPF) in Suspected Cases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06241560
Idiopathic Pulmonary Fibrosis, Lung Diseases
The Woodlands, Texas, United States
View Trial DetailsNCT05389215
Idiopathic Pulmonary Fibrosis, Lung Diseases
Mesa, Arizona, United States
View Trial DetailsNCT05241275
Idiopathic Pulmonary Fibrosis, Lung Diseases
Durham, North Carolina, United States
View Trial DetailsNCT06736990
Idiopathic Pulmonary Fibrosis, Lung Diseases
Los Angeles, California, United States
View Trial Details